Hematology Cell Bank

The Hematology Cell Bank of British Columbia (HCB) was established in September of 2005 to collect and store human biospecimens and related clinical data for scientific research into blood disease and malignancies. The objective of the Hematology Cell Bank of BC is to bring into practice the principles of translational research by encouraging open collaboration between scientists and clinicians, directly impacting the health outcomes of hematology patients.

The HCB represents a partnership between clinicians and staff of the Leukemia / Bone Marrow Transplant Program of BC, research scientists at the Terry Fox Laboratory, and collaborating scientists around the world. Specimens from consented patients and healthy donors are collected for researcher use. Access to specimen related clinical data is also available. Storage, processing and laboratory technician support is provided by the Stem Cell Assay Laboratory located at the British Columbia Cancer Research Centre.

The HCB is governed by a research ethics board approved protocol that outlines its operation and the scope of research permitted. Hematology Cell Bank operation is overseen by an advisory and research working group made up of clinician and researcher members. All specimens collected by the HCB and released for researcher use meet Research Ethics Board (REB) approval.

LaMP and the HCB would like to acknowledge and sincerely thank the patients that have donated their samples to this biorepository.

Flow Cytometry

The Flow Cytometry Core Facility (FCCF), is housed in the Terry Fox Laboratory and provides investigators at the British Columbia Cancer Research Centre access to high quality, cost effective flow cytometry services. By providing these services, as well as the scientific expertise necessary to effectively use this technology, the facility serves to enhance the scope and quality of scientific research performed at the centre.

Email: flowlab@bccrc.ca

Tel: 604-675-8145

Genetic Modelling Centre

The BC Cancer Center for Genetic Modeling (CGM) was initiated in 2004 as an expansion of the Terry Fox Laboratory Transgenics Core after a decade of successful operations. It is situated within the BC Cancer Research Center (BCCRC) building, which houses a 1,995 m2 rodent facility (ARC) that provides a barrier environment matching the highest standards of pathogen control for commercial facilities around the world. A biohazard Containment Level III facility, an Embryonic Stem (ES) cell lab, and mouse phenotyping suites also exist as infrastructure support for the CGM.

Email: nhofs@bccrc.ca

Back to top